(Q36578773)

15 August 2017

1 reference

title

The mechanisms, diagnosis, and management of severe asthma in adults (English)

1 reference

15 August 2017

1 reference

1

Stephen T Holgate

1 reference

15 August 2017

Riccardo Polosa

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

368

1 reference

15 August 2017

issue

9537

1 reference

15 August 2017

page(s)

780-793

1 reference

Most difficult asthma originates primarily in adult life

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Costs of asthma are correlated with severity: a 1-yr prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Severe asthma: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Features that distinguish those who die from asthma from community controls with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Difficult asthma in adults: recognition and approaches to management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Severe asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Childhood asthma and lung function in mid-adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Epithelial stress and structural remodelling in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Factors associated with persistent airflow limitation in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The influence of smoking on the treatment response in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Clinical phenotypes of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Phenotypes of asthma revisited upon the presence of atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Asthma may be more severe if it is work-related

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Cigarette smoking among asthmatic adults presenting to 64 emergency departments.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Deaths certified as asthma and use of medical services: a national case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Genetics of aspirin induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The broken balance in aspirin hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Difficult-to-control asthma and obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Role of vocal cord function and dysfunction in patients presenting with symptoms of acute asthma exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Interactions between psychosocial problems and management of asthma: who is at risk of dying?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Psychological factors associated with emergency room visits among asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Factors influencing gender differences in the diagnosis and treatment of asthma in childhood: the Tucson Children's Respiratory Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Relation between phase of the menstrual cycle and asthma presentations in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Interrelationships between asthma and pregnancy: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Hyperthyroidism and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

1 reference

7 January 2021

Association between leptin and asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Rhinosinusitis in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Gastro-oesophageal reflux treatment for asthma in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Severe asthma treatment: need for characterising patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Neutrophilic inflammation in severe persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Epithelial-mesenchymal interactions in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Involvement of the epidermal growth factor receptor in epithelial repair in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The airway epithelium: structural and functional properties in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Epithelial-mesenchymal communication in the pathogenesis of chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Thoracic CT in pediatric patients with difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Parameters associated with persistent airflow obstruction in chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Physiologic correlates of distal lung inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Relationship of small airway chymase-positive mast cells and lung function in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Corticosteroid therapy in asthma: predictors of responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Corticosteroid-insensitive asthma: molecular mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

1 reference

7 January 2021

The use of computed tomography to assess asthma severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Differences in airway remodeling between subjects with severe and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Impaired Perception of Dyspnea in Patients with Severe Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Mucus in chronic airway diseases: sorting out the sticky details

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Respiratory viruses and exacerbations of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Persistence of rhinovirus RNA after asthma exacerbation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Rhinovirus illnesses during infancy predict subsequent childhood wheezing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Bronchial CD8 cell infiltrate and lung function decline in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Air pollution and health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Risk of severe asthma episodes predicted from fluctuation analysis of airway function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Inhibition of tumor necrosis factor alpha for refractory asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

TNF-alpha dysregulation in asthma: relationship to ongoing corticosteroidtherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Airway structural alterations selectively associated with severe asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Synthetic responses in airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Do biophysical properties of the airway smooth muscle in culture predict airway hyperresponsiveness?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Contribution of the distal lung to the pathologic and physiologic changes in asthma: potential therapeutic target Roger S. Mitchell lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Alveolar tissue inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Distribution and degranulation of airway mast cells in normal and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Mast-cell infiltration of airway smooth muscle in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Multi-dimensional phenotyping: towards a new taxonomy for airway disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Severity assessment in asthma: An evolving concept

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The use of induced sputum to investigate airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Control of Exposure to Mite Allergen and Allergen-Impermeable Bed Covers for Adults with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Impact of Inhaled Corticosteroids on Acute Asthma Hospitalization in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Changes in the use of anti-asthmatic medication in an international cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Airway wall remodelling: the influence of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Macrolides for chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The effect of telithromycin in acute exacerbations of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Bilateral lung transplantation for severe persistent and difficult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Safety of long-acting beta-agonists--an urgent need to clear the air.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

beta-Adrenergic receptor polymorphisms and response to salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Long-acting β2 agonists and paediatric asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Anticholinergic agents for chronic asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Role of intravenous immunoglobulin in severe steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The role of sinus disease in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Characterisation of patients with frequent exacerbation of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The radiological spectrum of pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Successful treatment of a patient with severe Churg-Strauss syndrome by a combination of pulse corticosteroids, pulse cyclophosphamide, and high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Role of tumor necrosis factor alpha in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Evidence of a role of tumor necrosis factor alpha in refractory asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Cytokine and anti-cytokine therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

Psychological aspects of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969288-X

7 January 2021

10.1016/S0140-6736(06)69288-X

Identifiers

DOI

1 reference

release_iokn2kowcngtrlzcpae5mruzj4

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iokn2kowcngtrlzcpae5mruzj4

24 November 2022

mapped directly with Wikidata item

1 reference